New listings in AVMA Animal Health Studies Database – February 2023
Below are some of the new listings of veterinary clinical studies in the AVMA Animal Health Studies Database. Information about participation in the studies is available at the database site.
AAHSD005586: “Probiome for canine bladder cancer,” The Ohio State University.
AAHSD005588: “Can probiotics improve clinical outcomes in canine bladder cancer?: addition of probiotic Escherichia coli Nissle 1917 to a vinblastine piroxicam protocol for the treatment for urothelial carcinoma in dogs,” The Ohio State University, University of Missouri, and North Carolina State University.
AAHSD005591: “Evaluation of Laverdia-CA1 (verdinexor) for treatment of naive canine cutaneous epitheliotropic lymphoma,” University of Missouri.
AAHSD005593: “A field efficacy and safety pilot study of OKV-1001 for the treatment of chronic, non-seasonal moderate-to-severe atopic dermatitis,” University of Florida
AAHSD005596: “The evaluation of adaptation time in dogs undergoing limb amputation for osteosarcoma,” Colorado State University.
AAHSD005600: “Oral melanoma study in dogs,” University of Georgia; Friendship Hospital for Animals Washington, D.C.; The Oncology Service, Richmond, Virginia; The Oncology Service, Springfield, Virginia; BluePearl Pet Hospital, Malvern, Pennsylvania; BluePearl Pet Hospital, Overland Park, Kansas; Veterinary Specialty Hospital of Sorrento Valley, Sorrento Valley, California; VCA Animal Diagnostic Clinic, Dallas; VCA Veterinary Emergency Service & Specialty Center, Middleton, Wisconsin; and Newtown Veterinary Specialists, Newtown, Connecticut.
AAHSD005601: “HeEV: Histotripsy-enabled extracellular vesicle characterization in canine soft tissue sarcoma patients,” Animal Cancer Care and Research Center, Roanoke, Virginia.
AAHSD005602: “A field efficacy and safety pilot study of OKV-1001 for canine IMHA,” Cornell University and Louisiana State University.